Clinical trial
Edwards PASCAL Transcatheter Tricuspid Valve Repair System Coverage With Evidence Development Study (The CLASP III TR CED Study)
NCT07859709 is registered in ClinicalTrials.gov with Edwards Lifesciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Edwards PASCAL Transcatheter Tricuspid Valve Repair System Coverage With Evidence Development Study (The CLASP III TR CED Study)
- Lead sponsor
- Edwards Lifesciences
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- October 15, 2026
- Completion date
- October 31, 2033
- Enrollment
- 2,350 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cardiovascular diseases, heart diseases, heart valve diseases, tricuspid regurgitation, tricuspid valve insufficiency